Bureau Veritas Acquires Advanced Testing Laboratory, a US Leader in Scientific Sourcing
28 Juni 2022 - 08:11AM
Business Wire
Expanding BV’s footprint in Consumer Products
and Consumer Healthcare markets
Bureau Veritas, a world leader in testing, inspection
and certification, announced the acquisition of Advanced
Testing Laboratory (ATL), a leader in scientific sourcing services
for the North American Consumer Healthcare Products, Cosmetics
& Personal Care and Medical Device markets.
Headquartered in Cincinnati, Ohio, ATL’s services span the
entire product life cycle, from research and development to
substance and product qualification to manufacturing. Services
include Analytical Chemistry, Engineering, Life Science, Product
Performance, Product Safety & Regulatory, Quality Assurance and
Regulatory Compliance.
The company employs over 500 people all over the US. It
generated revenue of approximately €31 million in 2021.
Didier Michaud-Daniel, Chief Executive Officer of Bureau
Veritas, commented:
“In line with our 2025 Strategy, we are accelerating the
diversification of the Consumer Products Services division into new
markets and service models. Through its strong expertise in on-site
scientific sourcing solutions and in lab-based services, ATL will
contribute to the expansion of BV’s footprint in North America.
This major step in our development enables us to enter the
fast-growing Consumer Healthcare market. I would like to warmly
welcome the ATL teams to Bureau Veritas.”
Greg Neal, Chief Executive Officer of Advanced Testing
Laboratory, added:
“We are excited to join Bureau Veritas and look forward
to expanding the services we provide our clients while sharing our
unique scientific sourcing solution and framework worldwide.
Through our combined expertise, we will be able to offer a unique
scientific sourcing, supply chain management and ESG solution to
Consumer Healthcare Products and Medical Device brands. Our clients
will have access to a larger solutions support base with the
ability to replicate globally, amplifying the value to our ATL
client base.”
About Bureau Veritas
Bureau Veritas is a world leader in laboratory testing,
inspection and certification services. Created in 1828, the Group
has more than 80,000 employees located in nearly 1,600 offices and
laboratories around the globe. Bureau Veritas helps its 400,000
clients improve their performance by offering services and
innovative solutions in order to ensure that their assets,
products, infrastructure and processes meet standards and
regulations in terms of quality, health and safety, environmental
protection and social responsibility.
Bureau Veritas is listed on Euronext Paris and belongs to the
CAC 40 ESG, CAC Next 20 and SBF 120 indices.
Compartment A, ISIN code FR 0006174348, stock symbol: BVI.
For more information, visit www.bureauveritas.com, and follow us
on Twitter (@bureauveritas) and LinkedIn.
Our information is certified with blockchain technology.
Check that this press release is genuine at
www.wiztrust.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220627005837/en/
ANALYST/INVESTOR CONTACTS
Laurent Brunelle +33 (0)1 55 24 76 09
laurent.brunelle@bureauveritas.com
Colin Verbrugghe +33 (0)1 55 24 77 80
colin.verbrugghe@bureauveritas.com
MEDIA CONTACTS
Caroline Ponsi Khider +33 (0)7 52 60 89 78
caroline.ponsi-khider@bureauveritas.com
Primatice thomasdeclimens@primatice.com
armandrigaudy@primatice.com
Bureau Veritas (EU:BVI)
Historical Stock Chart
Von Feb 2023 bis Mär 2023
Bureau Veritas (EU:BVI)
Historical Stock Chart
Von Mär 2022 bis Mär 2023